The ParaSight™-F rapid dipstick antigen capture assay for monitoring parasite clearance after drug treatment of Plasmodium falciparum malaria

Author(s):  
Giovanni Di Perri ◽  
Piero Olliaro ◽  
Stefano Nardi ◽  
Benedetta Allegranzi ◽  
Roberto Deganello ◽  
...  
Author(s):  
Eduard Rovira-Vallbona ◽  
Nguyen Van Hong ◽  
Johanna H Kattenberg ◽  
Ro Mah Huan ◽  
Nguyen Thi Thu Hien ◽  
...  

Abstract Background Artemisinin-based combination therapies (ACTs) have significantly contributed to reduce Plasmodium falciparum malaria burden in Vietnam, but their efficacy is challenged by treatment failure of dihydroartemisinin/piperaquine ACT in Southern provinces. Objectives To assess the efficacy of dihydroartemisinin/piperaquine for uncomplicated P. falciparum malaria in Gia Lai, Central Vietnam, and determine parasite resistance to artemisinin (ClinicalTrials.gov identifier NCT02604966). Methods Sixty patients received either dihydroartemisinin/piperaquine (4 mg/kg/day, 3 days; n = 33) or artesunate monotherapy (4 mg/kg/day, 3 days; n = 27) followed by dihydroartemisinin/piperaquine (AS + DHA/PPQ). Clinical phenotypes were determined during a 42 day follow-up and analysed together with ex vivo susceptibility to antimalarials and molecular markers of drug resistance. Results Day 3 positivity rate was significantly higher in the AS + DHA/PPQ arm compared with dihydroartemisinin/piperaquine (70.4% versus 39.4%, P = 0.016). Parasite clearance time was 95.2 h (AS + DHA/PPQ) versus 71.9 h (dihydroartemisinin/piperaquine, P = 0.063) and parasite clearance half-life was 7.4 h (AS + DHA/PPQ) versus 7.0 h (dihydroartemisinin/piperaquine, P = 0.140). Adequate clinical and parasitological response at Day 42 was 100% in both arms. By RT–qPCR, 36% (19/53) patients remained positive until Day 7. No recurrences were detected. kelch13 artemisinin resistance mutations were found in 87% (39/45) of isolates and 50% (20/40) were KEL1/C580Y. The piperaquine resistance marker plasmepsin-2 was duplicated in 10.4% (5/48). Isolates from Day 3-positive patients (n = 18) had higher ex vivo survival rates to artemisinin compounds (P < 0.048) and prevalence of kelch13 mutations (P = 0.005) than Day 3-negative patients (n = 5). The WHO definition of artemisinin resistance was fulfilled in 60% (24/40) of cases. Conclusions Although dihydroartemisinin/piperaquine remained effective to treat P. falciparum, the high Day 3 positivity rate and prevalence of KEL1 strains calls for continuous monitoring of dihydroartemisinin/piperaquine efficacy in Central Vietnam.


2013 ◽  
Vol 12 (1) ◽  
pp. 115 ◽  
Author(s):  
Annemarie R Kreeftmeijer-Vegter ◽  
Mariana de Mendonça Melo ◽  
Peter J de Vries ◽  
Rob Koelewijn ◽  
Jaap J van Hellemond ◽  
...  

The Lancet ◽  
1997 ◽  
Vol 350 (9093) ◽  
pp. 1776
Author(s):  
Peter G Kremsner ◽  
Christian H Brandts ◽  
Maryse Ndjave ◽  
Wolfgang Graninger

Blood ◽  
2011 ◽  
Vol 117 (2) ◽  
pp. 381-392 ◽  
Author(s):  
Pierre A. Buffet ◽  
Innocent Safeukui ◽  
Guillaume Deplaine ◽  
Valentine Brousse ◽  
Virginie Prendki ◽  
...  

AbstractClinical manifestations of Plasmodium falciparum infection are induced by the asexual stages of the parasite that develop inside red blood cells (RBCs). Because splenic microcirculatory beds filter out altered RBCs, the spleen can innately clear subpopulations of infected or uninfected RBC modified during falciparum malaria. The spleen appears more protective against severe manifestations of malaria in naïve than in immune subjects. The spleen-specific pitting function accounts for a large fraction of parasite clearance in artemisinin-treated patients. RBC loss contributes to malarial anemia, a clinical form associated with subacute progression, frequent splenomegaly, and relatively low parasitemia. Stringent splenic clearance of ring-infected RBCs and uninfected, but parasite-altered, RBCs, may altogether exacerbate anemia and reduce the risks of severe complications associated with high parasite loads, such as cerebral malaria. The age of the patient directly influences the risk of severe manifestations. We hypothesize that coevolution resulting in increased splenic clearance of P. falciparum–altered RBCs in children favors the survival of the host and, ultimately, sustained parasite transmission. This analysis of the RBC–spleen dynamic interactions during P falciparum infection reflects both data and hypotheses, and provides a framework on which a more complete immunologic understanding of malaria pathogenesis may be elaborated.


The Lancet ◽  
1997 ◽  
Vol 350 (9079) ◽  
pp. 704-709 ◽  
Author(s):  
Christian H Brandts ◽  
Maryse Ndjavé ◽  
Wolfgang Graninger ◽  
Peter G Kremsner

Sign in / Sign up

Export Citation Format

Share Document